PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

Giving Thanks

November 28, 2020

Thanksgiving is a holiday of the heart, through the lens of gratitude. The year of COVID-19 has made that message shine brighter than any other year, if nothing else.

As we round the bend to sweep away 2020, we’ve been reminded of many things to be thankful...

Learn More

Behind the Scenes of Our Nurses Speak Up Video Series

November 28, 2020

Recently, I had the pleasure of virtually interviewing five operating room scrub nurses. I interviewed them as a part of our new video series, PackTalk: Nurses Speak Up. The goal of these interviews was to get real, honest feedback from healthcare...

Learn More

MedTech Conference Hot Topics

November 28, 2020

AdvaMed’s conference takes on medtech’s need to actively increase diversity and inclusion and fight racism, now.

If there is one thing we’ve learned in 2020, it is that our industry, along with others, must take a stand against racial injustice. AdvaMed’s...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.